69. LaForce, C.F., Carr, W., Tilles, S.A., Chipps, B.E., Storms, W., Meltzer, E.O., and Edwards, M. Evaluation of Olopatatadine Hydrochloride Nasal Spray, 0.6%, used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis. Allergy Asthma Proc. 2010; 31:132-140. View
68. Goldsobel, A., Chipps, B.E. Cough in Pediatric Population. Journal of Pediatrics 2010; 156 (3): 352-358. View
67. Benninger, M., Farrar J.R., Blaiss, M., Chipps, B.E., Ferguson, B., Krouse, J.,
Marple, B., Storms, W., and Kaliner, M. Evaluating Approved Medications to Treat Allergic Rhinitis in the United States: An Evidenced-Based Review of Efficacy for Nasal Symptoms by Class. Ann Allergy Asthma Immunol 2010; 104: 13-29. View
66. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, F.E.R.,
and Fish, J.E. Comparison of Asthma Exacerbations in Pediatric and Adult Patients with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 24:1106-1108. View
65. Haselkorn, T., Fish, J.E., Zeiger, R.S., Szefler, S.J., Miller, D.P., Chipps, B.E., Simons, E.R., Weiss, S.T., Wenzel, S.E., Borish, L., and Bleecker, E.R. Consistently Very Poorly Controlled Asthma by the Impairment Domain of the EPR-3 Guidelines Increases Risk for Future Severe Asthma Exacerbations in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study. J Allergy Clin Immunol 2009; 124: 895-902 e.4. View
64. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, E.R., and Fish, J.E. Recent Asthma Exacerbations Predict Future Exacerbations in Children with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 124: 921-927. View
63. Chipps B.E. and Harder J. Antihistamine treatment for allergic rhinitis: Different routes, different outcomes. Allergy Asthma Proc. 2009 November-December;30(6): 589-594. View